Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
32 hedge funds and large institutions have $56M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.78% less ownership
Funds ownership: 61.14% → 58.36% (-2.8%)
9% less funds holding
Funds holding: 35 → 32 (-3)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
77% less capital inflows, than outflows
Capital inflows: $758K | Capital outflows: $3.28M
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $296K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DMK
David M. Knott
|
+$225K |
| 2 |
JP Morgan Chase
New York
|
+$170K |
| 3 |
Renaissance Technologies
New York
|
+$113K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$55.7K |
| 5 |
Virtu KCG Holdings
New York
|
+$46.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.18M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$541K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$486K |
| 4 |
Credit Suisse
Zurich,
Switzerland
|
-$317K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$303K |
CORV Hedge Fund Activity: Q1 2017 in Review
32 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2017, worth a combined $56M — up 4.1% from $53.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CORV and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was David M. Knott, opening a new position worth an estimated $225K. The largest seller was Stonepine Capital Management, cutting an estimated $1.18M.
- 32 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2017, down from 35 in Q4 2016.
- Funds reported $56M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2017, up 4.1% quarter-over-quarter.
- 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2017 and 6 closed out, a net change of -2 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2017 was David M. Knott, an estimated $225K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2017 was Stonepine Capital Management, an estimated $1.18M sold.
Based on aggregated 13F filings for Q1 2017.